Adenosine and adenosine receptor-mediated action in coronary microcirculation
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Adenosine is an ubiquitous extracellular signaling molecule and plays a fundamental role in the regulation of coronary microcirculation through activation of adenosine receptors (ARs). Adenosine is regulated by various enzymes and nucleoside transporters for its balance between intra- and extracellular compartments. Adenosine-mediated coronary microvascular tone and reactive hyperemia are through receptors mainly involving A 2A R activation on both endothelial and smooth muscle cells, but also involving interaction among other ARs. Activation of ARs further stimulates downstream targets of H 2 O 2 , K ATP , K V and K Ca2+ channels leading to coronary vasodilation. An altered adenosine-ARs signaling in coronary microcirculation has been observed in several cardiovascular diseases including hypertension, diabetes, atherosclerosis and ischemic heart disease. Adenosine as a metabolite and its receptors have been studied for its both therapeutic and diagnostic abilities. The present review summarizes important aspects of adenosine metabolism and AR-mediated actions in the coronary microcirculation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Myocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Pepine, C. J., Anderson, R. D., Sharaf, B. L., Reis, S. E., Smith, K. M., Handberg, E. M., Johnson, B. D., Sopko, G., & Bairey Merz, C. N. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.054 · Cited by 805
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
Taqueti, V. R., & Di Carli, M. F. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.042 · Cited by 769
Hypoxic Dilation of Coronary Arteries Is Mediated by ATP-Sensitive Potassium Channels
Daut, J., Maier-Rudolph, W., von Beckerath, N., Mehrke, G., Günther, K., & Goedel-Meinen, L. (1990) · Science · doi:10.1126/science.2107575 · Cited by 593
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Severino, P., D'Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L. I., Netti, L., Montefusco, G., Chimenti, C., Lavalle, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218118 · Cited by 349
Adenosine-Mediated Effects of Ticagrelor
Cattaneo, M., Schulz, R., & Nylander, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.031 · Cited by 312
Cited by
Endothelial dysfunction in chronic kidney disease: a clinical perspective
Cho, M. E., Brunt, V. E., Shiu, Y.-T., & Bunsawat, K. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00908.2024 · Cited by 61
Xia, Y. F., He, F., Yacouba, M. B. M., Zhou, H., Li, J., Xiong, Y., Zhang, J., Li, H., Wang, Y., & Ke, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.755619 · Cited by 35
“Multiple angiocardiopathy, for instance, hypertension, atherosclerosis, diabetic cardiomyopathy, and ischemic heart disease have been related to changes in adenosine-adenosine receptor signaling in coronary microcirculation (4).”
BackgroundNicolau, A. M., Silva, P. G., Mejía, H. P. G., Granada, J. F., Kałuża, G. L., Burkhoff, D., Abizaid, T., Pileggi, B., Freire, A. F. D., Godinho, R. R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146835 · Cited by 33
“Its effects are primarily mediated through the adenosine A2A receptor, which promotes vasodilation on both endothelial and smooth muscle cells, and, by association, the production of NO and the activation of ATP-sensitive and voltage-dependent potassium channels (KATP) [119].”
Penna, C. R. R., Comità, S., Tullio, F., Alloatti, G., & Pagliaro, P. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.106995 · Cited by 28
Chen, Y., Chai, Q., Wang, Q., Zhang, Z., Shan, Y., Lu, D., Liu, M., & Wu, W. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108983 · Cited by 21
Purinergic signaling in myocardial ischemia–reperfusion injury
Zhuang, Y., Yu, M., & Lu, S.-F. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09856-4 · Cited by 17
“The downstream targets of P1 receptors are H2O2, KATP, KV, and KCa2+ channels [76].”
BackgroundWang, P., Gao, R., Wu, T., Zhang, J., Sun, X., Fan, F., Wang, C., Qian, S., Li, B., Zou, Y., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102884 · Cited by 16
Xie, Y., Nishijima, Y., Zinkevich, N. S., Korishettar, A., Fang, J., Mathison, A., Zimmermann, M. T., Wilcox, D. A., Gutterman, D. D., Shen, Y., et al. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00932-9 · Cited by 18
“Coronary microvascular impairment as a role of adjunct cardioprotection target has been gradually explored in recent years [24, 72], however, due to the limited knowl-”
BackgroundErythrocytes enhance oxygen-carrying capacity through self-regulation
Xu, Y., Yu, Z., Liu, H., Bian, X., & Tang, W. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1592176 · Cited by 17
Purinergic Signaling in Oral Tissues
Zuccarini, M., Giuliani, P., Ronci, M., Caciagli, F., Caruso, V., Ciccarelli, R., & Iorio, P. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147790 · Cited by 11
Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction
Zhou, Z. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09807-5 · Cited by 11
Self-citationYang, K., Shan, X., Songru, Y., Fu, M., Zhao, P., Guo, W., Xu, M., Chen, H., Lü, R., & Zhang, C. (2024) · Pharmaceutical Biology · doi:10.1080/13880209.2024.2354335 · Cited by 9
“Adenosine, an intrinsic purine nucleoside, plays a crucial role in controlling the cardiovascular system by engaging adenosine receptors (ADORs), which belong to the G protein-coupled receptor superfamily (Gaudry et al. 2020; Zhang et al. 2021).”
BackgroundDong, M., Zhao, C., Huang, Y., Zheng, K., Bao, G., Hu, F., Fan, P., Chen, M., Li, Z., & Lu, R. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115749 · Cited by 9
Valladão, S. C., França, A. P., Pandolfo, P., & dos Santos‐Rodrigues, A. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105771 · Cited by 8
Coronary Microvascular Dysfunction in Patients with Congenital Heart Disease
Vanreusel, I., Segers, V. F. M., Craenenbroeck, E. M. V., & Berendoncks, A. V. (2023) · Current Cardiology Reviews · doi:10.2174/1573403x19666230119112634 · Cited by 8
“Although adenosine is mostly classified as an endothelium-independent vasodilator [29], there is also literature stating that the vasodilator effect of adenosine is at least partially endothelium-dependent [61-63].”
BackgroundChen, T., Chang, Y.-C., Yu, C., & Sung, W. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091127 · Cited by 10
“The activation of A2AR on both endothelial and smooth muscle cells can lead to coronary vasodilation and reactive hyperemia [49], as adenosine regulates coronary microvascular tone and coronary blood flow.”
BackgroundLi, H., An, J. R., Park, M., Choi, J., Heo, R., Kang, M., Mun, S., Zhuang, W., Seo, M. S., Han, E., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175305 · Cited by 8
Lin, S., Landon, B., Zhang, H., & Jin, K. (2023) · Aging and Disease · doi:10.14336/ad.2023.0821-1 · Cited by 21
“Upon binding to specific ligands, a cascade of downstream signaling events is initiated, including the activation of the cAMP/PKA pathway and calcium signaling [25, 26].”
Backgroundvon Känel, R., Princip, M., Holzgang, S. A., Giannopoulos, A. A., Kaufmann, P. A., Buechel, R. R., Zuccarella‐Hackl, C., & Pazhenkottil, A. P. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111672 · Cited by 7
Liu, Y., Xu, T., Yu, Z. H., & Xu, B. (2024) · Brain and Behavior · doi:10.1002/brb3.70076 · Cited by 5
Tang, N., Li, K., Li, H., Zhang, Q., Ji, H., & Qi, C.-M. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i2.103950 · Cited by 11
“For example, miR-126 has been shown to promote endothelial repair by enhancing NO production and suppressing pro-inflammatory pathways[93].”
Wu, X., Yang, F., & Sun, L. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2022.2159426 · Cited by 5
“As an endothelium-independent vasodilator, Adenosine dilates coronary arteries by binding to A2 receptors in coronary smooth muscle cells (29).”
BackgroundBielinskyi, M. V., Seredyuk, N. M., Fedorov, S. V., Herashchenko, A. S., & Volynskyi, D. A. (2023) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.19.5.2023.1609 · Cited by 7
Protection against Ischemic Heart Disease: A Joint Role for eNOS and the KATP Channel
Severino, P., D’Amato, A., Mancone, M., Palazzuoli, A., Mariani, M. V., Prosperi, S., Myftari, V., Lavalle, C., Forleo, G. B., Birtolo, L. I., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097927 · Cited by 6
Wang, X., Gu, Z., Wan, J., Zhou, X., Zhu, K., Wang, X., Cao, X., Yu, X., Peng, X., & Tang, Y. Z. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124618 · Cited by 6
Self-citationvon Känel, R., Lodder, P., Holzgang, S. A., Princip, M., Giannopoulos, A. A., Buechel, R. R., Sivakumar, S., Zuccarella‐Hackl, C., & Pazhenkottil, A. P. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.041273 · Cited by 4
“Imaging was performed during rest, adenosine-induced hyperemia, reflecting endothelium-independent vasodilation, 36 and the CPT, reflecting endothelium-dependent vasodilation.”
Coronary flow velocity reserve with transthoracic echocardiography: a game changer
Picano, E. (2021) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2021.1980957 · Cited by 3
Baghdadi, A., Dunn, W. R., & Ralevic, V. (2025) · Purinergic Signalling · doi:10.1007/s11302-025-10086-7 · Cited by 3
“Adenosine/P1 receptors also regulate vascular contractility [28–30].”
Ku, K., Healy, J., Lee, C. A., Khan, M., Chao, K., Hassan, S., Tzeng, C.-F. T., Hsieh, Y.-L., Shedd, A., Bhakta, T., et al. (2025) · Medical Sciences · doi:10.3390/medsci13020058 · Cited by 7
“Chronic nicotine exposure may upregulate adenosine receptors, potentially enhancing its effects, warranting further research into tailored dosing strategies [20,43,44].”
Wang, Q., Zhang, Z., Chai, Q., Shan, Y., Lu, D., Chen, Y., Liu, M., & Wu, W. (2022) · European Journal of Ophthalmology · doi:10.1177/11206721221074201 · Cited by 3
Insulin Resistance ― Beginning of the Road to Coronary Microvascular Dysfunction and Beyond ―
Tanno, M., & Osanami, A. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0979 · Cited by 3
Geng, H., Zhou, Z., Meng, L., Zhuang, M., & Zhao, Y. (2026) · Metabolites · doi:10.3390/metabo16070478 · Cited by 2
“…and increased tissue perfusion demand, adenosine contributes to functional hyperemia and reactive vasodilation, primarily through activation of adenosine receptors on vascular smooth muscle and endothelial cells, thereby helping maintain the balance between local oxygen supply and demand [39,40].”
Self-citationInflammation mediated glycolipid dysregulation in coronary microvascular disease pathogenesis
Wen, W. X., Chi, Y., Liu, M., Gao, M., Xie, B., Yan, Y., Jin, Z., Jiang, L., Zhang, Y., Chen, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-08057-4 · Cited by 4
“IR mainly involve endothelium-independent mechanisms in which stimulation of both adenosine A1 and A2 receptors and the opening of ATP-sensitive potassium channels on smooth muscle cells play a role 51 .”
Self-citationCalenda, S., Ceni, C., Catarzi, D., Varano, F., Vagnoni, G., Bartolucci, G., Menicatti, M., Marucci, G., Buccioni, M., Ben, D. D., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108855 · Cited by 2
Xu, Q., Opoku, Y. N., Authi, K. S., & Cilibrizzi, A. (2025) · Cells · doi:10.3390/cells14151219 · Cited by 2
“Existing studies mainly focus on the acute use of AR-targeted compounds during ischemic events [80,125,126,128,146], as cardioprotection from adenosine has been considered to be highly timing-dependent–i.e., most of the action occurs when adenosine is administered just before or during the early…”
Natural vasodilators: mechanisms and therapeutic potential in cardiovascular diseases
Sun, A., Francis, O. B., Yan, S., Wang, J., Zhao, H., Leng, L., Li, R., Liu, H., Tian, X. L., Qi, D. A. K. E., et al. (2026) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000200 · Cited by 2
Persico, M., Micoli, A., Salmaso, V., Cianciulli, A., Moro, S., Spalluto, G., Buccioni, M., Marucci, G., Volpini, R., Pozzan, A., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00231 · Cited by 2
von Känel, R., Princip, M., Holzgang, S. A., Rossi, A., Giannopoulos, A. A., Buechel, R. R., Zuccarella‐Hackl, C., & Pazhenkottil, A. P. (2023) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001269 · Cited by 3
When should myocardial perfusion imaging be a first-test choice?
Rifai, M. A., & Winchester, D. E. (2024) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2024.101824 · Cited by 2
Hossain, M. Z., Ando, H., Roy, R. R., & Kitagawa, J. (2025) · Function · doi:10.1093/function/zqaf010 · Cited by 5
Potassium as an electro-metabolic signal for local coronary vasodilation
Tune, J. D., Duncker, D. J., Goodwill, A. G., Warne, C. M., Essajee, S. I., Tucker, S. M., Romero, S. A., Bender, S. B., Beard, D. A., Figueroa, C. A., et al. (2025) · Basic Research in Cardiology · doi:10.1007/s00395-025-01126-9 · Cited by 2
“Understanding precisely how coronary blood flow is coupled directly to the oxidative requirements of the heart has been the focus of much research [21, 47, 49].”
The nucleoside adenosine inhibits intracellular microvascular α2C-adrenoceptor surface trafficking
Shahwar, D. E., Saeed, M., Hazrat, H., Javaid, S., Mohsin, S., Ul‐Haq, Z., & Chotani, M. A. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133637 · Cited by 2
Cell-Cell Communication in the Vascular Endothelium
King, D. R., Mezache, L., Sedovy, M. W., Radwański, P., Johnstone, S. R., & Veeraraghavan, R. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_15 · Cited by 4
Lin, Y., Wang, H., Xu, J., Huang, Y., Gong, W., Wang, Q., Huang, Z., Xie, S., & Lin, J. (2021) · Journal of Biophotonics · doi:10.1002/jbio.202100172 · Cited by 2
Jiao, T., & Zhou, Z. (2025) · Purinergic Signalling · doi:10.1007/s11302-025-10081-y · Cited by 1
“Future studies should explore which cell types including endothelial cells, cardiomyocytes, or even circulating cells, such as red blood cells contribute to this ATP pool, as these can all release ATP in response to cellular stress [10, 11].”
Self-citationDu, J., Yang, K.-L., Yuan, Z., He, R., Liao, Q., Liu, S., Li, C., Meng, S., Long, X., Su, Q., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-16966-7 · Cited by 1
“Adenosine plays important roles in energy metabolism, vasodilation, and neural regulation, and also serves as a therapeutic target in various pharmacological applications 51,92 .”
Wang, B., & Zhang, J. (2025) · Food Chemistry X · doi:10.1016/j.fochx.2025.103386 · Cited by 1
“Two metabolites classified as nucleosides, nucleotides, and analogues (adenosine and methylthioadenosine) increased, and adenosine plays a key role in regulating coronary microcirculation through activation of adenosine receptors (Zhang et al., 2021).”
Zhang, K., Wang, S., Zhang, H., Ming, J., Long, W., & Fu, H. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118977 · Cited by 1
Singh, M. K., Yun, H. R., Ranbhise, J. S., Han, S., Seo, H., Yeo, S. G., Quan, F., Kim, S. S., & Kang, I. (2026) · Cells · doi:10.3390/cells15080682 · Cited by 2
Making sense of subcellular H2O2 in mammals
Waldeck‐Weiermair, M., Covington, T. A., Pandey, A. K., & Michel, T. M. (2026) · Redox Biochemistry and Chemistry · doi:10.1016/j.rbc.2026.100080 · Cited by 1
Chen, H., Yi, L., Luo, Y., & Zhou, Y. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118517 · Cited by 1
Yang, D.-H., Wang, J., Huo, Y.-Q., & Liu, Z.-P. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01854-1 · Cited by 1
“A different distribution of adenosine receptor subtypes has been observed along different branches of the coronary artery [32, 33].”
Guo, P., An, W., Guo, Y. C., Sun, Z., Wang, X., & Zhang, S. (2022) · Journal of Visualized Experiments · doi:10.3791/64121 · Cited by 1
Alisiddiq, Z., Sharma, H., Cotton, J. M., & Fan, L. M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1255643 · Cited by 1
Yoneyama, S., Hoyano, M., Ozaki, K., Ikegami, R., Kubota, N., Okubo, T., Yanagawa, T., Kurokawa, T., Akiyama, T., Washiyama, Y., et al. (2024) · Heart and Vessels · doi:10.1007/s00380-024-02438-x · Cited by 1
“Adenosine, a decomposition product of ATP, binds and activates adenosine A2a receptors on vascular cells [10].”
Regulation of transcription factor function by purinergic signalling in cardiovascular diseases
Tang, H., Kong, Q., Zhang, Z., Wu, W., Yuan, L., & Liu, X. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10045-8 · Cited by 1
“An excellent review summarized the role of adenosine receptors in coronary systole or diastole and suggested the importance of adenosine receptor sensitivity in ischaemic heart disease [68].”
InfluentialProgress in Drug Therapy of Coronary Microvascular Endothelial Dysfunction
张, 梦. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291171
Gao, Y. (2022) · Springer eBooks · doi:10.1007/978-981-19-7122-8_17
Local Metabolic Factors and Vasoactivity
Gao, Y. (2022) · Springer eBooks · doi:10.1007/978-981-19-7122-8_9
Adenosine, Regadenoson Stress Echocardiography
Boshchenko, A. A., Zhuravleva, O. A., Vrublevsky, A. V., & Picano, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31062-1_20
Zhongyu, H., Lyu, Z., You, H.-Z., Yaojuan, H., Lijuan, L., Li, S., Feng, S., & Li, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4198118/v1
Robinson, V. J. B., Chow, L., Mehta, V., & Oribabor, C. E. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.113871
Ceni, C., Calenda, S., Vagnoni, G., Catarzi, D., Varano, F., & Colotta, V. (2025) · Cells · doi:10.3390/cells14181480
“Peripherally, A 2A AR controls coronary vascular due to its expression in the smooth muscle and endothelium, where it induces vasodilation, thus providing a cardioprotective action [42].”
Platelet-Red Blood Cell Interactions
Krott, K. J., Feige, T., & Elvers, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-96344-5_12 · Cited by 1
Schmetterer, L. F., & Ismail, M. B. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_9
Tahirkheli, N. K., Zehra, M., Shahid, S., Islam, Z. U., Zahidi, M. A., Iqbal, M., Ahmad, A., Abid, M. S., Saeed, H., Ch, I., et al. (2026) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2025.104162
“21 This mechanism can be beneficial in the context of SVG PCI, where high plaque burdenand the potential fordistal embolization impair microvascular function.”
Thymidine induces macrophage M1 polarization in radiation-induced-lung-injury by ATF3/p38 pathway
Fan, H., Ge, X., Zhou, X., Zhang, P., Li, Y., Du, Z., Cheng, D., Lu, Y., Liu, Q., & Hu, Y. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105063
de Fondaumière, M. (2023) · theses.fr (ABES) · doi:10.70675/9dc73a0az2db9z4547zb5b3z6d65b7b632bc
Zhang, Y., Wang, Z., Li, R., Liu, Z., Zhang, R., Li, R., Wang, M., & Sun, G. Y. (2026) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010470039260325123335
Self-citationDesign of bioactive chitosan-adenosine composite coatings for vascular stents
Malisz, K., Pécastaings, G., Braczko, A., Kutryb-Zając, B. A., Grodzicka, M., Guitard, J., Bociąga, D., Mirowski, B., Świeczko‐Żurek, B., & Hellmann, M. (2026) · Applied Materials Today · doi:10.1016/j.apmt.2026.103276 · Cited by 1
Two Pulses per Beat: Parallel Energetics of Myocardium and Coronary Wall
Muñoz, M. F., & Santana, L. F. (2026) · Physiology · doi:10.1152/physiol.00023.2026
Huang, J., Miao, L., & Liu, Y. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1863045
“VO 2 max directly re fl ects the body ’ s ability to uptake, transport, and utilize oxygen under high-intensity exercise, serving as a key determinant of endurance performance and closely linked to cardiovascular health (Lee and Zhang, 2021).”
Metadata
- Authors
- Zhang, Y., Wernly, B., Cao, X., Mustafa, S. J., Tang, Y., & Zhou, Z.
- Affiliations
- Chengdu University of Traditional Chinese Medicine (CN)
- Paracelsus Medical University (AT)
- West Virginia University (US)
- Karolinska University Hospital (SE)
- Corresponding author
- Zhou, Zhichao
- Venue
- Basic Research in Cardiology
- Published
- 2021-03-23
- Volume
- 116
- Issue
- 1
- Pages
- 22-22
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- PMC
- PMC7987637
- OpenAlex
- W3136355169
- Cited by
- 71
- References
- 128
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 10 · 2023: 12 · 2022: 13 · 2021: 5
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Basic Research in Cardiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Hjärt-Lungfonden (20190341 and 20200326)
- Karolinska Institutet
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning (2018-01213, 2020-01209)
- Stiftelsen Lars Hiertas Minne (FO2018-0156)
- the National Key R&D Program of China (2019YFC1709101)
- the Project First-Class Disciplines Development of Chengdu University of Traditional Chinese Medicine (CZYHW1901)
- National Natural Science Foundation of China (81904306))
- the Science and Technology Program of Sichuan Province (20GJHZ0036)
- Karolinska Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- adenosine, adenosine receptors, coronary microcirculation, adenosine A2A receptor, reactive hyperemia, coronary vasodilation, endothelial cells, smooth muscle cells, nucleoside transporters, adenosine metabolism, ATP-sensitive potassium channels, potassium channels, hypertension, diabetes mellitus, atherosclerosis, ischemic heart disease
- MeSH terms
- Adenosine, Animals, Cardiovascular Diseases, Coronary Circulation, Coronary Vessels, Hemodynamics, Humans, Microcirculation, Potassium Channels, Signal Transduction, Receptors, Purinergic P1, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.